Dimitri Panayotopoulos
Senior Member of the Board of Advisors @ The Boston Consulting Group
Cincinnati, United States
Dimitri Panayotopoulos is a funding round investor at The Boston Consulting Group in Cincinnati focused on Biopharma and Health Care. Dimitri Panayotopoulos has been a non-executive member of Logitech's board of directors since December 2014 and serves on Logitech’s Compensation Committee.Dimitri Panayotopoulos is a senior advisor at The Boston Consulting Group, a global management consulting firm. Prior to joining The Boston Consulting Group in 2014, DimitriPanayotopoulos served with The Procter & Gamble Company (P&G), a consumer brand company, for over thirty years. At P&G, he held a variety of senior roles in regions across the world including vice chairman and advisor to the chairman & CEO from 2013 to 2014, vice chairman of Global Business Units from 2011 to 2013 and vice chairman of Global Household Care Group from 2007 to 2011. Dimitri Panayotopoulos’ previous roles at P&G included various executive, managerial and other positions in Europe (including Switzerland), Africa, China, Egypt and the Far East.At P&G, he held a variety of senior roles in regions across the world including vice chairman and advisor to the chairman & CEO from 2013 to 2014, vice chairman of Global Business Units from 2011 to 2013 and vice chairman of Global Household Care Group from 2007 to 2011. Dimitri Panayotopoulos’ previous roles at P&G included various executive, managerial and other positions in Europe (including Switzerland), Africa, China, Egypt and the Far East. serves on the board of directors of British American Tobacco p.l.c.Panayotopoulos holds a B.A. degree from Sussex University, U.K.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Dimitri Panayotopoulos invests in
Stages Dimitri Panayotopoulos invests in
Countries Dimitri Panayotopoulos invests in
Investment Focus
Industry
- Biopharma 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Legacy Healthcare
|
Legacy Healthcare is developping safer drugs for the treatment of autoimmune and inflammatory diseases in fragile patients | Jun 01, 2020 |
About The Boston Consulting Group
The Boston Consulting Group is a global management consulting firm and an advisor on business strategy. The firm partners with clients in all sectors and regions to identify their opportunities, address their critical challenges, and transform their businesses.The Boston Consulting Group was founded in July 1963 by Bruce Henderson and isheadquartered in Boston, Massachusetts. It has 82 offices in 46 countries.
The Boston Consulting Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Aliza Knox
Senior Advisor
|
|||
Christopher Freese
Senior Partner & Managing Director
|
|||
|
Dimitri Panayotopoulos
Senior Member of the Board of Advisors
|
|||
Elizabeth Kopp
Business Management Director, San Diego
|
|||
Evan Silberhorn
Principal and General Manager
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Dimitri Panayotopoulos invest in?
Dimitri Panayotopoulos invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Dimitri Panayotopoulos last invest?
The most recent investment recorded for Dimitri Panayotopoulos closed in Jun 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
